Homologous recombination repair status in advanced endometrial cancer: an exploratory biomarker analysis from the randomized, phase II MITOEND 3 trial
Michele Bartoletti, Anna Passarelli, Anna Fagotti, Claudio Andreetta et autres
it, us (code pays fourni par la source)